Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 AUD | +1.10% | +2.22% | +6.05% |
Mar. 19 | Cobram Estate Olives' Joint CEOs Sell Company Shares; Shares Climb 4% | MT |
Feb. 21 | Transcript : Cobram Estate Olives Limited, H1 2024 Earnings Call, Feb 21, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an expected P/E ratio at 58.84 and 14.93 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.63 times the sales for the current fiscal year, the company turns out to be overvalued.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.05% | 507M | - | ||
+30.16% | 7.01B | B+ | ||
+1.35% | 6.6B | C+ | ||
+2.80% | 5.29B | B | ||
+1.92% | 2.48B | B+ | ||
+42.70% | 2.22B | - | B- | |
-3.50% | 1.58B | C+ | ||
+18.18% | 1.05B | - | ||
+12.40% | 871M | B- | ||
+19.27% | 803M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CBO Stock
- Ratings Cobram Estate Olives Limited